Add BrightSurf on Google Email

NUS Medicine researchers identify promising broad-spectrum antiviral candidate against enteroviruses

Researchers have identified GW406108X, a broad-spectrum antiviral compound, that can inhibit a range of enteroviruses, including EV-D68, by targeting a process in human cells. The compound showed activity against multiple viruses, including Rhinovirus A16, and reduced EV-D68 levels by 1,000-fold in laboratory experiments.

Elucidating the underlying mechanism of Atg2-mediated lipid transfer in autophagy

Researchers have discovered the underlying mechanism of Atg2-mediated lipid transfer in autophagy, revealing two distinct mechanisms that enable proper growth of the autophagosomal membrane. The phosphorylation of a specific region of Atg2, mediated by Atg1, enables its binding to the endoplasmic reticulum and subsequent lipid transfer.

SourceInstitute of Science Tokyo·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 4, 2026

Combination treatment harnesses cellular recycling system to fight multiple myeloma

Researchers have developed an innovative combination treatment strategy that uses cells' waste removal functions to effectively dismantle multiple myeloma. The experimental targeted protein degrader enhances the destruction of a specific cancer cell survival protein and works in tandem with existing drugs, while showing limited toxicity.

SourceVirginia Commonwealth University·JournalCell Death and Disease·DateJul 13, 2026

Cellular recycling protein plays critical protective role in the gut

Researchers at Olivia Newton-John Cancer Research Institute discovered that reduced BECLIN1 levels weaken the gut's protective barrier, leading to increased susceptibility to inflammation and disease. This finding may help explain why some people are more susceptible to gut inflammation and associated diseases.

SourceOlivia Newton-John Cancer Research Institute·JournalCell Death and Disease·TypeExperimental study·DateJul 12, 2026

Scientists uncover two neuronal circuits orchestrating muscle autophagy

Researchers identified two parallel neuronal circuits regulating autophagy-lysosome pathway in C. elegans body wall muscle. The first circuit involves electrical synapses and the second originates from ASI sensory neurons, both converging on a Ca2+-calpain-lysosome signaling cascade to maintain muscle homeostasis.

SourceChinese Academy of Sciences Headquarters·JournalDevelopmental Cell·TypeExperimental study·DateJul 3, 2026

Cancer's hidden escape route

Prostate cancer cells use the PIM1 protein to survive treatment by activating autophagy, a cellular recycling process. Researchers have discovered a potential strategy to overcome this resistance by removing the PIM1 protein entirely using a proteolysis-targeting chimera.

SourceMedical University of South Carolina·JournalCancer Letters·TypeExperimental study·DateJun 16, 2026

Study identifies a key mechanism in the degeneration of motor neurons in ALS

A team of researchers has identified a key mechanism in the degeneration of motor neurons in ALS, revealing that chaperone-mediated autophagy is significantly reduced in patients. This finding suggests that this cellular system may be a potential therapeutic target to slow disease progression.

SourceUniversidad Miguel Hernandez de Elche·JournalActa Neuropathologica Communications·TypeExperimental study·DateApr 30, 2026

Sensing local fibers in pancreatic tumors, cancer cells ‘choose’ to either grow or tolerate treatment

A new study shows that pancreatic cancer cells' ability to detect the extracellular matrix determines their growth rate and response to chemotherapy. The researchers found that cells detecting ECM have low autophagy levels and high growth rates, while those farther away from ECM have high autophagy levels and can survive chemotherapy.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalCell·TypeExperimental study·DateFeb 16, 2026

The “broker” family helps tidy up the cell

A research team at Goethe University Frankfurt has compiled a catalog of human E3 ligases and mapped their relationships, revealing family-specific functions. The study identifies 40 additional E3 ligases suitable for PROTAC development, expanding the range of tissues and diseases targeted by degradation therapies.

SourceGoethe University Frankfurt·JournalNature Communications·TypeExperimental study·DateJan 15, 2026

Cold plunges actually change your cells, uOttawa study finds

A new study found that repeated cold exposure improves autophagic function in young males, enhancing cellular health and increasing cellular cold tolerance. This research provides scientific backing for the potential health benefits of cold water immersion and suggests its potential to prevent diseases and slow down aging.

SourceUniversity of Ottawa·JournalAdvanced Biology·TypeExperimental study·DateMar 28, 2025

An old drug with new tricks

A new study by MUSC researchers reveals how cancer cells develop resistance to hydroxychloroquine, an anti-malarial drug repurposed for cancer therapy. The findings suggest that targeting specific metabolic and export pathways can prevent resistance, opening the door for novel combination therapies.

SourceMedical University of South Carolina·JournalCell Cycle·TypeExperimental study·DateNov 4, 2024

Cellular liquid droplets can cut membranes

Scientists have found that biomolecular condensates can cross membranes without specialized cutting proteins, a process called wetting, which is essential for plant survival. The study shows that these liquid droplets can exert large capillary forces on membranes, cutting them in two and enabling material exchange between cell parts.

SourceUniversity of Cologne·JournalNature·TypeExperimental study·DateOct 14, 2024

Mechanism behind autophagy trigger unveiled

A research team led by Osaka University has identified a new mechanism crucial for the initiation of autophagy, a self-degradation process cells use to eliminate unneeded or damaged components. The palmitoylation of ULK1 by ZDHHC13 plays a critical role in this process.

SourceOsaka University·JournalNature Communications·TypeExperimental study·DateSep 24, 2024

Breaking MAD: Generative AI could break the internet

A recent study at Rice University found that using synthetic data to train generative AI models can lead to negative consequences, including model collapse and reduced quality. As models become increasingly dependent on self-consuming loops, they may produce warped outputs lacking diversity or quality.

SourceRice University·TypeData/statistical analysis·DateJul 30, 2024

GZ17-6.02 kills PDX isolates of uveal melanoma

Researchers found that GZ17-6.02 killed uveal melanoma cells by enhancing autophagy, inactivating key proteins, and reducing growth factors. The compound also interacted with doxorubicin and ERBB inhibitors to enhance tumor cell killing, suggesting potential as a single agent or combination therapy.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateMay 22, 2024

Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds

A new study found that genetic variants in lysosomal genes may contribute to the development of Parkinson's disease in individuals exposed to high levels of pesticides. The research suggests a potential gene-environment interaction, where minor changes in these genes can lead to increased disease risk under stress.

SourceUniversity of California - Los Angeles Health Sciences·Journalnpj Parkinson s Disease·TypeRandomized controlled/clinical trial·DateApr 25, 2024

Understanding jasmonic acid: A switch that activates autophagy in Arabidopsis petals

A team of researchers from Nara Institute of Science and Technology discovered a phytohormone-mediated switch controlling autophagy, leading to terminal cell differentiation for petal abscission. They found that jasmonic acid promotes petal abscission by activating autophagy at the base of petals.

SourceNara Institute of Science and Technology·JournalNature Communications·TypeExperimental study·DateFeb 7, 2024